GlassScriptPhysician profile
Robin Vee Krause
NPI 1659401214
$1,040.06
in general payments reported to CMS, 2019-2025
15 companies · $549 in 2025
The $549 reported for 2025 was more than what a typical Psychiatric/Mental Health, Adult (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $174).
See the full distribution for Psychiatric/Mental Health, Adult (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.73 · 2023: $26.19 · 2024: $372 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $356.51 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $107.16 | 2025 | Cobenfy |
| Lundbeck LLC | $99.02 | 2023-2025 | Abilify Maintena, Rexulti |
| Janssen Pharmaceuticals, INC | $76.10 | 2021-2025 | Spravato, Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $65.54 | 2024-2025 | Caplyta |
| Indivior INC. | $61.58 | 2024-2025 | Sublocade, Perseris |
| Teva Pharmaceuticals USA, INC. | $51.03 | 2023-2025 | Austedo Xr, Uzedy |
| Otsuka America Pharmaceutical, INC. | $43.42 | 2024-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Corium, LLC | $40.22 | 2024 | Azstarys |
| Acadia Pharmaceuticals INC | $36.36 | 2025 | Nuplazid |
| Vanda Pharmaceuticals INC. | $31.54 | 2024-2025 | Hetlioz, Fanapt |
| Alkermes, INC. | $24.51 | 2021 | |
| Axsome Therapeutics, INC. | $18.62 | 2025 | Auvelity |
| Luye Pharma (USA) LTD. | $14.39 | 2025 | Erzofri Extended-Release |
| Takeda Pharmaceuticals U.S.A., INC. | $14.06 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Krause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.